190 related articles for article (PubMed ID: 12018890)
1. The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation.
Salerno M; Petroutsa M; Garnier-Suillerot A
J Bioenerg Biomembr; 2002 Apr; 34(2):135-45. PubMed ID: 12018890
[TBL] [Abstract][Full Text] [Related]
2. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
Vernhet L; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
Biochem Pharmacol; 2001 Jun; 61(11):1387-91. PubMed ID: 11331074
[TBL] [Abstract][Full Text] [Related]
3. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required.
Leslie EM; Haimeur A; Waalkes MP
J Biol Chem; 2004 Jul; 279(31):32700-8. PubMed ID: 15161912
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells.
Salerno M; Garnier-Suillerot A
Eur J Pharmacol; 2001 Jun; 421(1):1-9. PubMed ID: 11408043
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
Chen J; Cheng J; Yi J; Xie B; Lin L; Liu Z; Zhao H; Wang B; Ai Z; Yang Y; Wei H
Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
[TBL] [Abstract][Full Text] [Related]
7. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells.
Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Akiyama S
Biochem Biophys Res Commun; 1997 Jul; 236(3):586-90. PubMed ID: 9245693
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivities of MRP1-overexpressing lung tumor cells to cytotoxic metals.
Vernhet L; Allain N; Bardiau C; Anger JP; Fardel O
Toxicology; 2000 Jan; 142(2):127-34. PubMed ID: 10685512
[TBL] [Abstract][Full Text] [Related]
9. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
Yang CH; Kuo ML; Chen JC; Chen YC
Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
[TBL] [Abstract][Full Text] [Related]
11. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines.
Davison K; Côté S; Mader S; Miller WH
Leukemia; 2003 May; 17(5):931-40. PubMed ID: 12750708
[TBL] [Abstract][Full Text] [Related]
12. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an arsenic trioxide-resistant human leukemia cell line that shows multidrug resistance.
Seo T; Urasaki Y; Ueda T
Int J Hematol; 2007 Jan; 85(1):26-31. PubMed ID: 17261498
[TBL] [Abstract][Full Text] [Related]
14. Transport of antimony salts by Arabidopsis thaliana protoplasts over-expressing the human multidrug resistance-associated protein 1 (MRP1/ABCC1).
Gayet L; Picault N; Cazalé AC; Beyly A; Lucas P; Jacquet H; Suso HP; Vavasseur A; Peltier G; Forestier C
FEBS Lett; 2006 Dec; 580(30):6891-7. PubMed ID: 17150215
[TBL] [Abstract][Full Text] [Related]
15. Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice.
Lorico A; Bertola A; Baum C; Fodstad O; Rappa G
Biochem Biophys Res Commun; 2002 Mar; 291(3):617-22. PubMed ID: 11855834
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 activation ameliorates cytotoxic effects of arsenic trioxide in acute promyelocytic leukemia cells through increased glutathione levels and arsenic efflux from cells.
Nishimoto S; Suzuki T; Koike S; Yuan B; Takagi N; Ogasawara Y
Toxicol Appl Pharmacol; 2016 Aug; 305():161-168. PubMed ID: 27317373
[TBL] [Abstract][Full Text] [Related]
17. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
[TBL] [Abstract][Full Text] [Related]
18. Resistance to arsenic- and antimony-based drugs.
Salerno M; Garnier-Suillerot A
Bioinorg Chem Appl; 2003; 1(2):189-98. PubMed ID: 18365053
[TBL] [Abstract][Full Text] [Related]
19. Increased biliary excretion of glutathione is generated by the glutathione-dependent hepatobiliary transport of antimony and bismuth.
Gyurasics A; Koszorús L; Varga F; Gregus Z
Biochem Pharmacol; 1992 Oct; 44(7):1275-81. PubMed ID: 1417951
[TBL] [Abstract][Full Text] [Related]
20. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1.
Bagrij T; Klokouzas A; Hladky SB; Barrand MA
Biochem Pharmacol; 2001 Jul; 62(2):199-206. PubMed ID: 11389878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
